Authors




Greg A. Muffler

Latest:

Technology for Adherence

Technology that helps increase communication can improve patient outcomes.


Lynn Pezzullo, RPh

Latest:

Medication Management: Measuring What Matters

As new care delivery models evolve to focus on value, accountability, and team-based care, new measure development opportunities exist to address care gaps and to support team-based care delivery systems and care transitions.


Molly Culbertson

Latest:

Best Practices in Transforming Chronic Pain Care

The number of opioids prescribed in the Untied States was approximately 3 times as high in 2015 as it was in 1999.


Deanna L. Hall, PharmD, CDE, BCACP

Latest:

Pandemic Vaccine Planning: Lessons Learned and Preparing for the Future

The variations between seasonal and pandemic influenza necessitate the use of different approaches when planning vaccination delivery within the pharmacy.


Gina Upchurch, BSPharm, RPh, MPH

Latest:

Patient Advocacy: It's Not Just About the Medications

Relationships built on mutual trust and respect are the foundation for the Senior PharmAssist program.


Chris Edgar, PhD

Latest:

Digital Health and Clinical Trials

To date, significant uncertainty surrounds the adoption of digital health tools into clinical development programs and trial protocols.


Alexandra San Roman, BA

Latest:

Do Units and Costs of Comparable Insulins Differ by Manufacturer?

Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.



Joseph L. Fink II, BSPharm, JD

Latest:

House Bill Takes Aim at Direct-to-Consumer Advertising

Direct-to-consumer advertising is a continuously growing sector of the pharmaceutical industry’s cost expenditure.


Scott W. Savage, Jill Bates

Latest:

Challenges Continue for True Patient-Centered Access

Access to oral chemotherapies is filled with challenges for providers and patients that can be significant, resulting in delayed therapy.


Edmund Pezalla, MD, MPH

Latest:

Diabetes: The Next Chapter

We have the tools to make an impact on the incidence of type 2 diabetes and to improve secondary prevention of cardiovascular mortality.


Dick Creager, MD, MPA

Latest:

The Impact of Abuse Deterrent Technologies on Prescription Opioid Trends

The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.


Beth Lofgren, PharmD, BCPS

Latest:

Experience or Residency? What Is Really Important?

Over time, pharmacy is evolving into something different.


Nova Simpson, PharmD

Latest:

5 New Year's Resolutions for the Pharmacy Team

Make a commitment to make the workplace a cleaner, happier, and healthier place in 2018.


Michelle Krichbaum, PharmD

Latest:

Vulvodynia Study Endorsing Gabapentin for Pelvic Muscle Pain: An In-depth Look

Using a drug that increases GABA synthesis and possibly escalates intraneuronal dopamine in a population that is more likely to have behavior health concerns may prove to be an unsafe option.


Leonardo R.L. Pereira, PhD

Latest:

Contributions of Pharmacists in the Treatment of Epilepsy: A Systematic Review

The treatment of epilepsy is complex and can cause drug-related problems and hamper quality of life. Clinical services performed by pharmacists may optimize the pharmacotherapy and avoid or mitigate these problems.


Dean Pham, PharmD

Latest:

National Panel Updates Its Asthma Guideline

The National Asthma Education and Prevention Program's Expert Panel has issued revised guidelines for treating asthma in children and adults.


Rusol Karralli, PharmD, MS

Latest:

340B Audit: Building a Self-Audit Program

The 340B program launched in 1992 to “stretch scarce federal resources” in order for participating entities to increase accessibility to care (eg, medications, clinical services, etc) for patients.


Heather Brand, PharmD, MSPBA

Latest:

Patient Satisfaction – The True Differentiator for Specialty Pharmacies

A growing number of specialty pharmacy contractual agreements with payers and manufacturers have patient satisfaction metrics built in.


Suresh Kumar

Latest:

Sanofi Appoints Suresh Kumar to the Executive Committee and Executive Vice President, External Affairs

Sanofi today announced the appointment of Suresh Kumar as a new member of the Executive Committee, effective June 1, 2015.


By Sandra Fyfe, MA

Latest:

Study: Clinical Pharmacist Recommendations Increased with Rapid Diagnostic Testing in Community Hospitals

Rapid diagnostic testing resulted in providers receiving a large increase in pharmacist recommendations in 2 community hospital settings.


Dewilka Simons

Latest:

A Guide to G6PD Deficiency

Glucose-6-phosphate dehydrogenase is an enzyme involved in the pentose phosphate pathway and maintaining levels of co-enzyme nicotinamide adenine dinucleotide phosphate


Quintin Jessee, PharmD

Latest:

URAC Accreditation Update: Getting Prepared

Vital information on the URAC accreditation process is presented that will help specialty pharmacies prepare. Watch for subsequent articles on the 5 main URAC specialty pharmacy modules of standards.


Rita Hammer, PharmD candidate

Latest:

The Role of Pharmacists in Diabetes Management During COVID-19

Pharmacists offer a variety of services that can help patients to manage diabetes and other chronic conditions, especially during the COVID-19 pandemic.


Jacques Turgeon, PhD, BPharm

Latest:

Telepharmacy Offers Opportunity Amid Pandemic

The contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.


Lee J. Smolen, BSEE

Latest:

Cost-Effectiveness of Live Attenuated Versus Inactivated Influenza Vaccine Among Children

Vaccination with trivalent live attenuated versus inactivated influenza vaccine in children aged 2 to 17 years is cost saving or cost-effective depending on the severity of the influenza season.



Kathy Tang, PharmD

Latest:

Antimicrobial Stewardship: A Primer for Hospital Pharmacists

The CDC has reported that 20% to 50% of all antibiotics prescribed in US acute care hospitals are either unnecessary or inappropriate, resulting in avoidable adverse effects, bacterial resistance, and an increased incidence of infection.